您的购物车当前为空
BC-1215 是一种 F-box protein 3 抑制剂。它能够稳定 TRAF1-TRAF6 来抑制 Fbxo3-TRAF 激活途径。它与 ApaG 相互作用,阻碍来自人 PBMC 广谱 TH1 细胞因子的分泌。


为众多的药物研发团队赋能,
让新药发现更简单!
BC-1215 是一种 F-box protein 3 抑制剂。它能够稳定 TRAF1-TRAF6 来抑制 Fbxo3-TRAF 激活途径。它与 ApaG 相互作用,阻碍来自人 PBMC 广谱 TH1 细胞因子的分泌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 221 | In stock | |
| 2 mg | ¥ 297 | In stock | |
| 5 mg | ¥ 496 | In stock | |
| 10 mg | ¥ 795 | In stock | |
| 25 mg | ¥ 1,290 | In stock | |
| 50 mg | ¥ 1,830 | In stock | |
| 100 mg | ¥ 2,570 | In stock |
BC-1215 相关产品
| 产品描述 | BC-1215 is an inhibitor of F-box protein 3 (FBXO3, a ubiquitin E3 ligase component, IC50=0.9 μg/mL for IL-1β release). |
| 靶点活性 | FBXO3:0.9 μg/mL |
| 体内活性 | BC-1215 是一种靶向靶向 Fbxo3 的小分子抑制剂,已足以在多种小鼠疾病模型中减轻由细胞因子驱动的炎症的严重程度。 |
| 动物实验 | Tested effects of administration of BC-1215 in a model of a cecal ligation and puncture (CLP)-induced sepsis. Mice with CLP had significantly increased cytokine release compared to sham treated mice. BC-1215 treatment significantly attenuated CLP-induced secretion of all three circulating pro-inflammatory cytokines in mice . BC-1215 also decreased bacterial counts in the CLP model and modestly produced inhibition of bacterial growth using Kirby Bauer testing |
| 分子量 | 394.51 |
| 分子式 | C26H26N4 |
| CAS No. | 1507370-20-8 |
| Smiles | C(CNCc1ccc(cc1)-c1ccccn1)NCc1ccc(cc1)-c1ccccn1 |
| 密度 | 1.125 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| 溶解度信息 | DMSO: 3.94 mg/mL (9.99 mM), Sonication is recommended. | |||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.53 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
| ||||||||||||||||
评论内容